Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease
Authors
Keywords
Celiac disease, Soluble syndecan-1, Epithelial barrier, Biomarker
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 62, Issue 3, Pages 755-760
Publisher
Springer Nature
Online
2016-12-26
DOI
10.1007/s10620-016-4415-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge
- (2016) Marlou P M Adriaanse et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Rheumatoid arthritis–celiac disease relationship: Joints get that gut feeling
- (2015) Aaron Lerner et al. AUTOIMMUNITY REVIEWS
- Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease
- (2015) Aaron Lerner et al. AUTOIMMUNITY REVIEWS
- Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease
- (2015) Doron Yablecovitch et al. DIGESTIVE DISEASES AND SCIENCES
- Advances in Diagnosis and Management of Celiac Disease
- (2015) Ciarán P. Kelly et al. GASTROENTEROLOGY
- Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation
- (2015) Zhongqiu Wang et al. INFLAMMATORY BOWEL DISEASES
- High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression
- (2015) Qing Qing et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn’s Disease
- (2015) Cem Çekiç et al. Gastroenterology Research and Practice
- The Role of Gluten in Celiac Disease and Type 1 Diabetes
- (2015) Gloria Serena et al. Nutrients
- Matrix Expansion and Syncytial Aggregation of Syndecan-1+ Cells Underpin Villous Atrophy in Coeliac Disease
- (2014) Camilla Salvestrini et al. PLoS One
- Syndecan-1 and Heparanase
- (2013) Shaoheng Zhang et al. INFLAMMATORY BOWEL DISEASES
- The Oslo definitions for coeliac disease and related terms
- (2012) Jonas F Ludvigsson et al. GUT
- Characterization of Heparin-binding Site of Tissue Transglutaminase
- (2012) Zhuo Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The adaptive immune response in celiac disease
- (2012) Shuo-Wang Qiao et al. Seminars in Immunopathology
- Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis
- (2011) Martine Heyman et al. GUT
- Heparan Sulfate Proteoglycans
- (2011) S. Sarrazin et al. Cold Spring Harbor Perspectives in Biology
- Activated Syndecan-1 Shedding Contributes to Mice Colitis Induced by Dextran Sulfate Sodium
- (2010) Xia Wang et al. DIGESTIVE DISEASES AND SCIENCES
- Proteoglycans in health and disease: the multiple roles of syndecan shedding
- (2010) Tina Manon-Jensen et al. FEBS Journal
- Enoxaparin Improves the Course of Dextran Sodium Sulfate-Induced Colitis in Syndecan-1-Deficient Mice
- (2009) Martin Floer et al. AMERICAN JOURNAL OF PATHOLOGY
- Gliadin Induces an Increase in Intestinal Permeability and Zonulin Release by Binding to the Chemokine Receptor CXCR3
- (2008) Karen M. Lammers et al. GASTROENTEROLOGY
- Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma
- (2008) Anurag Purushothaman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function
- (2008) Lars Bode et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More